Adaptive Nanomedicinal Compositions for Breast Cancer Treatment in Specialized Environments

Publication ID: 24-11857639_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Nanomedicinal Compositions for Breast Cancer Treatment in Specialized Environments,” Published Technical Disclosure No. 24-11857639_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857639_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,639.

Summary of the Inventive Concept

A novel approach to breast cancer treatment using nanomedicinal compositions tailored for specific, high-stakes environments, such as high-security facilities, disaster relief scenarios, extreme weather conditions, remote rural areas, and space exploration settings.

Background and Problem Solved

The original patent disclosed a nanomedicinal composition for breast cancer treatment, but its limitations in terms of transport, storage, and administration in unique operational environments prompted the development of specialized variations to address these gaps.

Detailed Description of the Inventive Concept

The new inventive concept adapts the original nanomedicinal composition to meet the demands of specific, high-stakes environments. For instance, the composition is designed for secure transport and storage in high-security facilities, or for use in portable, emergency medical kits in disaster relief scenarios. In extreme weather conditions, the composition is engineered to withstand extreme temperatures and humidity. For remote, rural areas, the composition is optimized for transport via unmanned aerial vehicles (UAVs). In space exploration settings, the composition is tailored for use in microgravity environments. These adaptations enable effective breast cancer treatment in environments where traditional compositions may be impractical or ineffective.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original nanomedicinal composition, including secure transport and storage designs, portable emergency medical kits, extreme weather-resistant formulations, UAV-transportable compositions, and microgravity-compatible designs. These adaptations constitute a non-obvious, inventive step beyond the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include adaptations for other high-stakes environments, such as military operations or search and rescue missions. Variations could also include different nanocarrier materials, magnetic ferrite particle sizes, or pharmaceutical agent mixtures tailored to specific environments or applications.

Potential Commercial Applications and Market

The adaptive nanomedicinal compositions have significant commercial potential in industries such as healthcare, pharmaceuticals, and biotechnology, particularly in specialized markets catering to high-security facilities, disaster relief organizations, and space exploration agencies.

CPC Classifications

SectionClassGroup
A A61 A61K47/6923
A A61 A61K31/138
A A61 A61K31/282
A A61 A61K33/243
A A61 A61K47/10
A A61 A61K2121/00
A A61 A61K2800/47
B B82 B82Y5/00
B B82 B82Y25/00
B B82 B82Y30/00
B B82 B82Y40/00

Field of Art

Nanomedicine, pharmaceutical compositions, cancer treatment technologies, with expertise in nanocarrier design, magnetic nanoparticle engineering, and targeted drug delivery systems

Person of Ordinary Skill (PHOSITA) Profile

A researcher with advanced degrees in materials science, chemical engineering, or pharmaceutical sciences, possessing knowledge of nanoparticle synthesis, drug encapsulation techniques, and medical device adaptation for specialized environments

Obviousness Rationale

A person having ordinary skill would recognize that the fundamental nanomedicinal composition from US 11857639 can be readily adapted to different environmental contexts by applying standard engineering principles of material modification and contextual optimization. The core technological elements remain consistent across the variations, with modifications representing predictable design adaptations for specific use cases. The PTD demonstrates routine engineering problem-solving by extending the original nanomedicinal composition's applicability through targeted environmental adjustments.

Obvious Combinations & Variations

Source Patent Element
Nanocarrier with mesosilicalite and magnetic ferrite particles for breast cancer treatment
PTD Variation
Adapting the nanocarrier for high-security facility transport and storage
Obviousness Reasoning
A PHOSITA would recognize that modifying packaging and containment protocols represents a standard engineering design choice for sensitive medical technologies, using known security and preservation techniques
Source Patent Element
Pharmaceutical composition with anti-cancer therapeutic and antioxidant
PTD Variation
Designing portable emergency medical kit configurations
Obviousness Reasoning
Developing compact, transportable medical delivery systems is a predictable solution for expanding treatment accessibility, utilizing known medical packaging and preservation technologies
Source Patent Element
Nanocarrier with specific particle size ranges (25-500 nm for mesosilicalite, 5-50 nm for magnetic ferrite)
PTD Variation
Engineering compositions to withstand extreme temperatures and humidity
Obviousness Reasoning
Material science techniques for enhancing nanoparticle stability through compositional and structural modifications represent standard engineering problem-solving approaches
Source Patent Element
Nanomedicinal composition for targeted drug delivery
PTD Variation
UAV-transportable compositions for remote area treatment
Obviousness Reasoning
Adapting medical technologies for alternative delivery mechanisms is a predictable extension of existing drug delivery research, representing an obvious solution to expanding treatment accessibility
Source Patent Element
Pharmaceutical composition with magnetic nanocarrier
PTD Variation
Microgravity-compatible design for space exploration settings
Obviousness Reasoning
Modifying nanoparticle compositions to function in alternative environmental conditions represents a routine engineering challenge with predictable solution strategies
35 U.S.C. § 103 Summary: Based on the teachings of US 11857639, the disclosed nanomedicinal composition variations represent obvious extensions of the original patent's technological framework, demonstrating that a person having ordinary skill in the art would find the proposed adaptations to be predictable modifications achievable through standard engineering problem-solving techniques, thereby rendering potential derivative claims obvious and non-patentable.

Original Patent Information

Patent NumberUS 11,857,639
TitleMethod for treating breast cancer
Assignee(s)Imam Abdulrahman Bin Faisal University